Hepacivirus (MeSH) < Hepacivirus (drug effects) < Hepacivirus (genetics)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Hepacivirus (drug effects)

Number of relevant bibliographic references: 15.

Ident.	Authors (with country if any)	Title
000227 (2019)	Di Dem Özer Etik [Turquie] ; Nuretdin Suna ; Serkan Öcal ; Haldun Selçuk ; Ülkü Da L ; Turan Çolak ; Fatih Hilmio Lu ; Ahmet Sedat Boyac O Lu ; Mehmet Haberal	Successful Treatment With Direct-Acting Antiviral Agents of Hepatitis C in Patients With End-Stage Renal Disease and Kidney Transplant Recipients.
000298 (2019)	Mei-Yueh Lee [Taïwan] ; Wei-Chun Chen [Taïwan] ; Wei-Hao Hsu [Taïwan] ; Szu-Chia Chen [Taïwan] ; Jin-Ching Lee [Taïwan]	Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism.
000494 (2018)	José A. Del Campo [Espagne] ; Marta García-Valdecasas [Espagne] ; Antonio Gil-G Mez [Espagne] ; Ángela Rojas [Espagne] ; Paloma Gallego [Espagne] ; Javier Ampuero [Espagne] ; Rocío Gallego-Durán [Espagne] ; Helena Pastor [Espagne] ; Lourdes Grande [Espagne] ; Francisco J. Padillo [Espagne] ; Jordi Muntané [Espagne] ; Manuel Romero-G Mez [Espagne]	Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
000588 (2018)	A. Weigert [Portugal] ; S. Querido [Portugal] ; L. Carvalho [Portugal] ; L. Lebre [Portugal] ; C. Chagas [Portugal] ; P. Matias [Portugal] ; R. Birne [Portugal] ; C. Nascimento [Portugal] ; C. Jorge [Portugal] ; T. Adragão [Portugal] ; M. Bruges [Portugal] ; D. Machado [Portugal]	Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.
000859 (2017)	A. Frey [Allemagne] ; E-M Ecker [Allemagne] ; K. Piras-Straub [Allemagne] ; A. Walker [Allemagne] ; T G Hofmann [Allemagne] ; J. Timm [Allemagne] ; B B Singer [Allemagne] ; G. Gerken [Allemagne] ; K. Herzer [Allemagne]	Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
000A48 (2016)	Wei-Liang Liu [Taïwan] ; Hung-Chih Yang [Taïwan] ; Ching-Sheng Hsu [Taïwan] ; Chih-Chiang Wang [Taïwan] ; Tzu-San Wang [Taïwan] ; Jia-Horng Kao [Taïwan] ; Ding-Shinn Chen [Taïwan]	Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
000A66 (2016)	Ming-Ling Chang [Taïwan]	Metabolic alterations and hepatitis C: From bench to bedside.
000E72 (2014)	Ozan Yazici [Turquie] ; Mehmet Ali Nahit Sendur [Turquie] ; Sercan Aksoy [Turquie]	Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.
000F46 (2013)	Hui Chen [République populaire de Chine] ; Li Ye ; Jin-Ming Su ; Yu Li ; Jin-Rong Zeng ; Wen-Zhe Huo	[Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
000F81 (2013)	Amin Soliman [Égypte] ; Ahmed Fathy ; Sahier Khashab ; Noha Shaheen ; Mahmoud Soliman	Sirolimus conversion may suppress viral replication in hepatitis C virus-positive renal transplant candidates.
001042 (2013)	He Huang [République populaire de Chine] ; Rongyan Kang ; Ji Wang ; Guangxiang Luo ; Wei Yang ; Zhendong Zhao	Hepatitis C virus inhibits AKT-tuberous sclerosis complex (TSC), the mechanistic target of rapamycin (MTOR) pathway, through endoplasmic reticulum stress to induce autophagy.
001140 (2012)	Audrey Coilly [France] ; Valérie Furlan ; Bruno Roche ; Caroline Barau ; Coralie Noël ; Laurence Bonhomme-Faivre ; Teresa Maria Antonini ; Anne-Marie Roque-Afonso ; Didier Samuel ; Anne-Marie Taburet ; Jean-Charles Duclos-Vallée	Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.
001155 (2012)	Li Ye [République populaire de Chine] ; Jieliang Li ; Ting Zhang ; Xu Wang ; Yizhong Wang ; Yu Zhou ; Jinping Liu ; Hemant K. Parekh ; Wenzhe Ho	Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.
001294 (2011)	Masao Honda [Japon] ; Kenji Takehana ; Akito Sakai ; Yusuke Tagata ; Takayoshi Shirasaki ; Shinobu Nishitani ; Takahiko Muramatsu ; Tatsuya Yamashita ; Yasunari Nakamoto ; Eishiro Mizukoshi ; Yoshio Sakai ; Taro Yamashita ; Mikiko Nakamura ; Tetsuro Shimakami ; Minkyung Yi ; Stanley M. Lemon ; Tetsuo Suzuki ; Takaji Wakita ; Shuichi Kaneko	Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.
001297 (2011)	G J Mckenna [États-Unis] ; J F Trotter ; E. Klintmalm ; N. Onaca ; R. Ruiz ; L W Jennings ; M. Neri ; J G O'Leary ; G L Davis ; M F Levy ; R M Goldstein ; G B Klintmalm	Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Hepacivirus (drug effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Hepacivirus (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Hepacivirus (drug effects)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020